Abiopharma

🔍 Kirol Charles Peter (Executive)

Company: PELOTON INTERACTIVE, INC. (PTON)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 56,510 shares of Class A Common Stock (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 144,918.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 19,806 shares of Class A Common Stock at $5.0205 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 125,112.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 56,510 shares of Restricted Stock Unit (RSU) (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 452,080.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• F2: The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs.
• F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.0200 to $5.0650 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: The RSUs vest quarterly in equal 1/12 installments, commencing July 15, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.